Viking Therapeutics Inc (NAS:VKTX)
$ 62.76 1.98 (3.25%) Market Cap: 6.95 Bil Enterprise Value: 5.80 Bil PE Ratio: 0 PB Ratio: 7.32 GF Score: 38/100

Viking Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Oct 2, 2019 / 08:45 PM GMT
Release Date Price: $6.9 (+2.07%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VKTX.OQ - Viking Therapeutics Inc
Viking Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference
Oct 02, 2019 / 08:45PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Company Representative [1]
--------------------------------------------------------------------------------
Thanks for the opportunity to speak here. It looks like a very good conference and we appreciate the invitation, so thanks very much. I will be making some forward-looking statements and encourage those listening to this presentation to refer to the Securities and Exchange Commission website for the most current information on the Company.

So walking through the story today, we are a San Diego-based biotech company and we have a portfolio of small molecule drugs focused on what we believe to be first-in-class or best-in-class therapeutics for metabolic and endocrine disorders. We have data from two Phase 2 programs reported over the past 24 months that suggest very
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot